Why the Vonoprazan Helicobacter pylori Therapies in the US-European Trial Produced Unacceptable Cure Rates. Graham DY. Dig Dis Sci 2023 Mar 1. doi: 10.1007/s10620-023-07886.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Graham DY. Why the Vonoprazan Helicobacter pylori Therapies in the US-European Trial Produced Unacceptable Cure Rates. Dig Dis Sci 2023 Mar 1. doi: 10.1007/s10620-023-07886.
PMID: 36856926